Jerome Benedict Durso
CIK 1698665 · President and CEO · last filed 2026-04-01
Jerome Benedict Durso is a President and CEO who has filed 39 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing shows the insider bought $47.1K of ALT on Apr 1, 2026. Across all open-market trades the lifetime net is +$169.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $124.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$124.0K
2
39
$169.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALT | President and CEO | 47,500 | $2.61 | $124.0K | $169.5K | 6 | 2026-04-01 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | President & CEO | 154,640 | $19.00 | $2.94M | $0 | 32 | 2023-01-31 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-01 | ALT | Buy (P) | +15,000 | $47.1K | EDGAR |
| 2026-03-09 | ALT | Buy (P) | +20,000 | $70.8K | EDGAR |
| 2025-12-22 | ALT | Buy (P) | +12,500 | $51.6K | EDGAR |
| 2025-12-01 | ALT | Grant (A) | — | $0 | EDGAR |
| 2025-09-29 | ALT | Grant (A) | — | $0 | EDGAR |
| 2025-02-25 | ALT | Grant (A) | — | $0 | EDGAR |
| 2023-11-13 | — | Mixed | −154,640 | -$2.94M | |
| 2023-01-31 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +50,400 | $0 | EDGAR |
| 2023-01-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −7,083 | -$87.6K | EDGAR |
| 2022-01-31 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +35,700 | $0 | EDGAR |